申请人:Boehringer Markus
公开号:US20060135561A1
公开(公告)日:2006-06-22
The present invention relates to compounds of the formula (I)
wherein R
1
and R
2
are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, non-insulin dependent diabetes mellitus and/or impaired glucose tolerance, obesity, and/or metabolic syndrome or β-cell protection.
本发明涉及如下式(I)的化合物,其中R1和R2如描述和权利要求中所定义,并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与DPP-IV相关的疾病,如糖尿病、非胰岛素依赖型糖尿病和/或糖耐量受损、肥胖和/或代谢综合征或β-细胞保护。